Research News |
 |
| MAF plans to use the funds to award grants to the world's leading colleges of veterinary medicine, organizations, and scientists |
MAF launches $30m Canine Cancer Campaign
The Morris Animal Foundation (MAF) has launched a $30m fundraising initiative called the Canine Cancer Campaign, which aims to cure cancer in dogs within the next two decades. The US-based animal research fundraising organization has already received a $1.1m donation from Pfizer Animal Health for the cause, and hopes that, in addition to other corporate sponsorships, $22m will be raised from donations of at least $50 made by 1% of the 44 million dog-owning households in the US over the next five years.
MAF plans to use the funds to award grants to the world's leading colleges of veterinary medicine, organizations, and scientists. The grants will be used to develop innovative therapies to alleviate suffering from cancer in dogs, conduct prevention studies related to genetics and the canine genome, fund a tumor tissue bank, and establish an endowment to guarantee continued research efforts.
MAF says that one in four dogs will die of cancer, and that it is the leading cause of death in dogs over the age of two. It also says that 60% of golden retrievers die of cancer, and different breeds are more susceptible to different types of cancer.
"Each of our own pet dogs is at risk to suffer the devastating effects of cancer," said MAF president and chief executive Dr Patricia N Olson. "Sadly, many of the most popular dog breeds are especially susceptible to developing cancer."
Efforts to learn more about canine cancer are also expected to shed light about the disease in other species.
"Comparative and translational research acknowledges that cancer is cancer regardless of species, and that discoveries in either dogs or humans will have rapid acceptance in the other species," said Dr Stephen Withrow, director of the Animal Cancer Center at Colorado State University.
Established in 1948, MAF is based in Denver, Colorado, and has raised close to $50m for nearly 1,300 animal health studies. More information about MAF and the Canine Cancer Campaign can be found at www.morrisanimalfoundation.com.
Comments? Email: richard.daub@informausa.com |
|
 |
| DNA samples provide key to size variance in dog breeds |
Study explains wide size variance of dog breeds
A team of international researchers has published a study that offers an explanation as to why different breeds of dogs vary so widely in size....
To access the full content, subscribe to
Pharm Fresh, our FREE weekly briefing. |
|
The Animal Pharm Industry Excellence Awards 2007 |
Date: 25 September 2007
Venue: Gibson Hall, London
Entry Deadline: Friday, 18 May 2007
The Animal Pharm Industry Excellence Awards is the first and only platform designed to recognize and celebrate the achievements of those working in the animal health care industry.
The 13 award categories have been developed to focus on the rapidly evolving animal health industry and have been selected after industry and market consultation. The awards are open to any animal health company, of any size, operating around the world, as well as companies that supply to the animal health industry.
• Enter by downloading the pdf form
• Book a table
• Visit the website |
|
Podcast |
Over-the-counter: Overlooked or overrated?
Breaking into the animal health market via the "ethical" channel is costly, especially for new entrants. Does OTC open up a more attractive and more cost-effective sales route for distributors and manufacturers? Podcast and feature by Drs John Hales & Sarah J Hales. Listen to the podcast |
|
Research
Roundup |
The Canadian Veterinary Journal, April 2007 (Canadian Veterinary Medical Association)
Portacaval shunt in a calf: Clinical, pathologic, and ultrasonographic findings
Sébastien Buczinski, Julie Duval, Marc-André d’Anjou, David Francoz, Gilles Fecteau.
Successful treatment of nasal sporotrichosis in a dog
Jacqueline C Whittemore, Craig B Webb.
Veterinary medicine for a world in crisis
Frederick A Leighton. |
|
The Journal of Parasitology, February 2007
(The American Society of Parasitologists)
The use of MM3 monoclonal antibodies for the early immunodiagnosis of ovine fascioliasis
Mezo M, Gonzalez-Warleta M, Ubeira FM.
|
|
Vaccine, April 2007 (Elsevier)
Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice
Ochoa J, Irache JM, Tamayo I, Walz A, Delvecchio VG,
Gamazo C. |
|
|
|
|
|
|